Literature DB >> 22528658

Structural basis of interleukin-5 dimer recognition by its α receptor.

Seisuke Kusano1, Mutsuko Kukimoto-Niino, Nobumasa Hino, Noboru Ohsawa, Masashi Ikutani, Satoshi Takaki, Kensaku Sakamoto, Miki Hara-Yokoyama, Mikako Shirouzu, Kiyoshi Takatsu, Shigeyuki Yokoyama.   

Abstract

Interleukin-5 (IL-5), a major hematopoietin, stimulates eosinophil proliferation, migration, and activation, which have been implicated in the pathogenesis of allergic inflammatory diseases, such as asthma. The specific IL-5 receptor (IL-5R) consists of the IL-5 receptor α subunit (IL-5RA) and the common receptor β subunit (βc). IL-5 binding to IL-5R on target cells induces rapid tyrosine phosphorylation and activation of various cellular proteins, including JAK1/JAK2 and STAT1/STAT5. Here, we report the crystal structure of dimeric IL-5 in complex with the IL-5RA extracellular domains. The structure revealed that IL-5RA sandwiches the IL-5 homodimer by three tandem domains, arranged in a "wrench-like" architecture. This association mode was confirmed for human cells expressing IL-5 and the full-length IL-5RA by applying expanded genetic code technology: protein photo-cross-linking experiments revealed that the two proteins interact with each other in vivo in the same manner as that in the crystal structure. Furthermore, a comparison with the previously reported, partial GM-CSF•GM-CSFRA•βc structure enabled us to propose complete structural models for the IL-5 and GM-CSF receptor complexes, and to identify the residues conferring the cytokine-specificities of IL-5RA and GM-CSFRA.
Copyright © 2012 The Protein Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528658      PMCID: PMC3403420          DOI: 10.1002/pro.2072

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  62 in total

1.  Structural design and molecular evolution of a cytokine receptor superfamily.

Authors:  J F Bazan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 2.  Cytokine signaling through nonreceptor protein tyrosine kinases.

Authors:  T Taniguchi
Journal:  Science       Date:  1995-04-14       Impact factor: 47.728

3.  Protein photo-cross-linking in mammalian cells by site-specific incorporation of a photoreactive amino acid.

Authors:  Nobumasa Hino; Yuko Okazaki; Takatsugu Kobayashi; Akiko Hayashi; Kensaku Sakamoto; Shigeyuki Yokoyama
Journal:  Nat Methods       Date:  2005-02-17       Impact factor: 28.547

4.  JAK2 and JAK1 constitutively associate with an interleukin-5 (IL-5) receptor alpha and betac subunit, respectively, and are activated upon IL-5 stimulation.

Authors:  N Ogata; T Kouro; A Yamada; M Koike; N Hanai; T Ishikawa; K Takatsu
Journal:  Blood       Date:  1998-04-01       Impact factor: 22.113

5.  The interleukin-5/receptor interaction activates Lyn and Jak2 tyrosine kinases and propagates signals via the Ras-Raf-1-MAP kinase and the Jak-STAT pathways in eosinophils.

Authors:  R Alam; K Pazdrak; S Stafford; P Forsythe
Journal:  Int Arch Allergy Immunol       Date:  1995 May-Jun       Impact factor: 2.749

6.  Slow-dissociation effect of common signaling subunit beta c on IL5 and GM-CSF receptor assembly.

Authors:  Tetsuya Ishino; Adrian E Harrington; Meirav Zaks-Zilberman; Jeffery J Scibek; Irwin Chaiken
Journal:  Cytokine       Date:  2008-02-21       Impact factor: 3.861

7.  Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist.

Authors:  J Tavernier; T Tuypens; A Verhee; G Plaetinck; R Devos; J Van der Heyden; Y Guisez; C Oefner
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

8.  Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex.

Authors:  Martin J Boulanger; Dar-chone Chow; Elena E Brevnova; K Christopher Garcia
Journal:  Science       Date:  2003-06-27       Impact factor: 47.728

9.  Identification of the second subunit of the murine interleukin-5 receptor: interleukin-3 receptor-like protein, AIC2B is a component of the high affinity interleukin-5 receptor.

Authors:  S Takaki; S Mita; T Kitamura; S Yonehara; N Yamaguchi; A Tominaga; A Miyajima; K Takatsu
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  14 in total

Review 1.  Role of the β Common (βc) Family of Cytokines in Health and Disease.

Authors:  Timothy R Hercus; Winnie L T Kan; Sophie E Broughton; Denis Tvorogov; Hayley S Ramshaw; Jarrod J Sandow; Tracy L Nero; Urmi Dhagat; Emma J Thompson; Karen S Cheung Tung Shing; Duncan R McKenzie; Nicholas J Wilson; Catherine M Owczarek; Gino Vairo; Andrew D Nash; Vinay Tergaonkar; Timothy Hughes; Paul G Ekert; Michael S Samuel; Claudine S Bonder; Michele A Grimbaldeston; Michael W Parker; Angel F Lopez
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

2.  Elastin-like polypeptide switches: A design strategy to detect multimeric proteins.

Authors:  Jugal P Dhandhukia; Dab A Brill; Aida Kouhi; Martha K Pastuszka; J Andrew MacKay
Journal:  Protein Sci       Date:  2017-07-05       Impact factor: 6.725

3.  Switchable elastin-like polypeptides that respond to chemical inducers of dimerization.

Authors:  Jugal Dhandhukia; Isaac Weitzhandler; Wan Wang; J Andrew MacKay
Journal:  Biomacromolecules       Date:  2013-03-05       Impact factor: 6.988

4.  Crystallization and preliminary X-ray diffraction analysis of the interleukin-3 alpha receptor bound to the Fab fragment of antibody CSL362.

Authors:  Sophie E Broughton; Timothy R Hercus; Tracy L Nero; Urmi Dhagat; Catherine M Owczarek; Matthew P Hardy; Louis J Fabri; Pierre D Scotney; Andrew D Nash; Nicholas J Wilson; Angel F Lopez; Michael W Parker
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-02-19       Impact factor: 1.056

Review 5.  Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab.

Authors:  Corrado Pelaia; Alessandro Vatrella; Maria Teresa Busceti; Luca Gallelli; Rosa Terracciano; Rocco Savino; Girolamo Pelaia
Journal:  Drug Des Devel Ther       Date:  2017-10-30       Impact factor: 4.162

6.  Modulation of Interleukin-12 activity in the presence of heparin.

Authors:  Srinivas Jayanthi; Bhanu Prasanth Koppolu; Khue G Nguyen; Sean G Smith; Barbara K Felber; Thallapuranam Krishnaswamy Suresh Kumar; David A Zaharoff
Journal:  Sci Rep       Date:  2017-07-13       Impact factor: 4.379

Review 7.  Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?

Authors:  Gilda Varricchi; Gianenrico Senna; Stefania Loffredo; Diego Bagnasco; Matteo Ferrando; Giorgio Walter Canonica
Journal:  Front Immunol       Date:  2017-03-10       Impact factor: 7.561

8.  Active vaccination against interleukin-5 as long-term treatment for insect-bite hypersensitivity in horses.

Authors:  Antonia Fettelschoss-Gabriel; Victoria Fettelschoss; Florian Olomski; Katharina Birkmann; Franziska Thoms; Maya Bühler; Martin Kummer; Andris Zeltins; Thomas M Kündig; Martin F Bachmann
Journal:  Allergy       Date:  2018-11-25       Impact factor: 13.146

9.  Structural and evolutionary exploration of the IL-3 family and its alpha subunit receptors.

Authors:  Jade Fogha; Jagadeesh Bayry; Julien Diharce; Alexandre G de Brevern
Journal:  Amino Acids       Date:  2021-07-01       Impact factor: 3.520

10.  A dual role for the N-terminal domain of the IL-3 receptor in cell signalling.

Authors:  Sophie E Broughton; Timothy R Hercus; Tracy L Nero; Winnie L Kan; Emma F Barry; Mara Dottore; Karen S Cheung Tung Shing; Craig J Morton; Urmi Dhagat; Matthew P Hardy; Nicholas J Wilson; Matthew T Downton; Christine Schieber; Timothy P Hughes; Angel F Lopez; Michael W Parker
Journal:  Nat Commun       Date:  2018-01-26       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.